Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation Norditropin for female infertility. Lansdale: HAYES, Inc.. Directory Publication. 2012 Authors' conclusions Recombinant human growth hormone has been used as an adjunctive treatment for female infertility in women undergoing ovarian stimulation protocols that may or may not be part of in vitro fertilization procedures. The goal of these treatments is to enhance the ovarian response to hormonal stimulation and ultimately to increase the rates of pregnancies and live births. Indexing Status Subject indexing assigned by CRD MeSH Human Growth Hormones; Infertility, Female Language Published English Country of organisation United States English summary An English language summary is available. Address for correspondence HAYES, Inc., 157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218 Email: hayesinfo@hayesinc.com AccessionNumber 32013000196 Date abstract record published 25/03/2013 |